Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Shield Therapeutics Plc
November 2024 Investor Forum
21st Nov 2024
Custodian Property Income REIT plc
November 2024 Investor Forum
20th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
105: Finding the venture opportunity in the energy transition | Reuben Wilcock of Blackfinch Ventures
Stay up-to-date with the latest research
Sign up to our newsletter
Life Sciences research
Allergy Therapeutics plc
Life Sciences
Continuing to gain market share
By
Dr Martin Hall
10 Oct 2017
ValiRx
Life Sciences
Progressing all the pipeline
06 Oct 2017
Stay up-to-date with the latest research
Sign up to our newsletter
Scancell Holdings
Life Sciences
Preparing for next clinical studies
By
Dr Martin Hall
03 Oct 2017
Advanced Oncotherapy
Life Sciences
Technology advances & stronger balance sheet
By
Dr Martin Hall
02 Oct 2017
ValiRx
Life Sciences
Positive early data from VAL401
28 Sep 2017
Collagen Solutions Plc
Life Sciences
Engineering towards CE Mark
By
Dr Martin Hall
21 Sep 2017
Collagen Solutions Plc
Life Sciences
Delivering biomaterials for revenue growth
By
Dr Martin Hall
15 Sep 2017
Diurnal Group Plc
Life Sciences
Ready to press the button
By
Dr Martin Hall
14 Sep 2017
ValiRx
Life Sciences
GeneICE and VAL101 progress
13 Sep 2017
Oxford BioMedica
Life Sciences
New era for cell and gene therapies
12 Sep 2017
Oxford BioMedica
Life Sciences
Ready for CTL019 approval
24 Aug 2017
Prev
1
...
17
18
19
20
21
22
Next
